Clinical trial

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

NCT07702461

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-06-12

PhaseN/A

Study timeline

Study start (actual)2026-06-12Date precision: day

Registry last updated2026-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesity & Overweightunresolved

Diabetes (DM)unresolved

Interventions

Glucagon-Like Peptide-1 Agonist (GLP-1)DRUG

Sponsors & collaborators

Ohio State Universitylead sponsor

Mapped research locations

ColumbusOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07702461 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.